Seroatlas · Human Serome Atlas

E2F5

Transcription factor E2F5

Also known as: E2F5_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q15329
Gene
E2F5
Ensembl
ENSG00000133740
Chromosome
8
Canonical length
346 aa
Protein class
Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors
Subcellular location
Nucleoplasm,Nucleoli,Vesicles

OverviewNCBI Gene

The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionarily conserved domains that are present in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein is differentially phosphorylated and is expressed in a wide variety of human tissues. It has higher identity to E2F4 than to other family members. Both this protein and E2F4 interact with tumor suppressor proteins p130 and p107, but not with pRB. Alternative splicing results in multiple variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

346 residues, UniProt reviewed canonical sequence.

>Q15329|E2F5
     1  MAAAEPASSG QQAPAGQGQG QRPPPQPPQA QAPQPPPPPQ LGGAGGGSSR HEKSLGLLTT
    61  KFVSLLQEAK DGVLDLKAAA DTLAVRQKRR IYDITNVLEG IDLIEKKSKN SIQWKGVGAG
   121  CNTKEVIDRL RYLKAEIEDL ELKERELDQQ KLWLQQSIKN VMDDSINNRF SYVTHEDICN
   181  CFNGDTLLAI QAPSGTQLEV PIPEMGQNGQ KKYQINLKSH SGPIHVLLIN KESSSSKPVV
   241  FPVPPPDDLT QPSSQSLTPV TPQKSSMATQ NLPEQHVSER SQALQQTSAT DISSAGSISG
   301  DIIDELMSSD VFPLLRLSPT PADDYNFNLD DNEGVCDLFD VQILNY

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against E2F5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.54
Highest tissue expression
28 nTPM

Expression across tissuesHPA

Tissue

  • tonsil: 28 nTPM
  • lymph node: 24 nTPM
  • parathyroid gland: 12 nTPM
  • thymus: 9.9 nTPM
  • thyroid gland: 8.2 nTPM
  • testis: 7.9 nTPM

Single-cell type

  • b-cells: 86 nCPM
  • plasma cells: 61 nCPM
  • thymocytes: 60 nCPM
  • cardiomyocytes: 54 nCPM
  • pdcs: 42 nCPM
  • megakaryocyte-erythroid progenitors: 41 nCPM

Immune cell

  • memory B-cell: 14 nTPM
  • naive B-cell: 8.9 nTPM
  • plasmacytoid DC: 1.5 nTPM
  • NK-cell: 1.4 nTPM
  • T-reg: 0.6 nTPM
  • total PBMC: 0.6 nTPM

Brain region

  • hypothalamus: 4.7 nTPM
  • medulla oblongata: 4 nTPM
  • white matter: 3.8 nTPM
  • midbrain: 3.4 nTPM
  • basal ganglia: 3.3 nTPM
  • spinal cord: 3.3 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.36
gnomAD pLI
0.94
gnomAD missense Z
0.86
DepMap mean gene effect
0.06
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads E2F5 as an antibody target. Whether an autoantibody or antibody against E2F5 could matter depends on whether native E2F5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

E2F5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label E2F5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/E2F5. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...